The serine/threonine protein phosphatase type 5 (PP5) is a promising target for designing new antitumor drugs. This enzyme is a member of the PPP phosphatases gene family, which catalyzes a dephosphorylation reaction: a regulatory process in the signal transduction pathway that controls various biological processes. The aim of this work is to study and compare the inhibition of PP5 by ten cantharidin-like inhibitors in order to bring about contributions relevant to the better comprehension of their inhibitory activity. In this theoretical investigation, we used molecular dynamics techniques to understand the role of key interactions that occur in the protein active site; QM calculations were employed to study the interaction mode of these inhibitors in the enzyme. In addition, atoms in molecules (AIM) calculations were carried out to characterize the chemical bonds among the atoms involved and investigate the orbital interactions with their respective energy values. The obtained results suggest that the Arg275, Asn303, His304, His352, Arg400, His427, Glu428, Val429, Tyr451, and Phe446 residues favorably contribute to the interactions between inhibitors and PP5. However, the Asp271 and Asp244 amino acid residues do not favor such interactions for some inhibitors. Through the QM calculations, we can suggest that the reactional energy of the coordination mechanism of these inhibitors in the PP5 active site is quite important and is responsible for the inhibitory activity. The AIM technique employed in this work was essential to get a better comprehension of the transition states acquired from the mechanism simulation. This work offers insights of how cantharidin-like inhibitors interact with human PP5, potentially allowing the design of more specific and even less cytotoxic drugs for cancer treatments. Graphical Abstract Interactions of cantharidin-like inhibitors with human protein phosphatase-5 in a Mg2+ system.

Center for Basic and Applied Research Faculty of Informatics and Management University of Hradec Kralove Hradec Kralove Czech Republic

Laboratory of Computational Chemistry Department of Chemistry Federal University of Lavras 3027 Campus Universitario Lavras 37200000 Minas Gerais Brazil

Laboratory of Molecular Modeling Department of Chemistry Federal University of São João del Rei Rua Sebastião Gonçalves Coelho 400 Divinópolis MG 35501 296 Brazil

Laboratory of Molecular Simulation of Material Department of Physics Federal University of Ouro Preto Campus Universitário Morro do Cruzeiro Ouro Preto MG CEP 35400 000 Brazil

Zobrazit více v PubMed

Nucleic Acids Res. 2000 Jan 1;28(1):235-42 PubMed

J Mol Model. 2015 Jan;21(1):14 PubMed

Comb Chem High Throughput Screen. 2016;19(4):334-44 PubMed

J Chem Inf Model. 2009 Jun;49(6):1428-36 PubMed

J Med Chem. 2009 Aug 13;52(15):4838-43 PubMed

Cancer Metastasis Rev. 2008 Jun;27(2):169-78 PubMed

J Biomed Sci. 2014 Sep 20;21:84 PubMed

Proc Natl Acad Sci U S A. 2016 Aug 9;113(32):9009-14 PubMed

J Biol Chem. 2004 Aug 6;279(32):33992-9 PubMed

Cell. 2013 Dec 5;155(6):1199-202 PubMed

Biochem Pharmacol. 2016 Jun 1;109:14-26 PubMed

Int J Mol Sci. 2013 Dec 16;14(12):24501-13 PubMed

Expert Opin Ther Pat. 2016;26(3):389-407 PubMed

Chemistry. 2013 Oct 11;19(42):14081-9 PubMed

J Mol Graph. 1996 Feb;14(1):33-8, 27-8 PubMed

Int J Biochem Cell Biol. 2008;40(11):2358-62 PubMed

Trends Endocrinol Metab. 2001 Jan-Feb;12(1):28-32 PubMed

Angew Chem Int Ed Engl. 2009;48(7):1198-229 PubMed

Curr Med Chem. 2016;23(10):1041-61 PubMed

J Biomol Struct Dyn. 2015 Sep;33(9):2048-58 PubMed

Sci Rep. 2015 Jul 20;5:12359 PubMed

Cell. 2009 Oct 30;139(3):468-84 PubMed

Methods Enzymol. 2016;577:119-58 PubMed